SYK Q3 2024 Earnings — Stryker Corporation Revenue & Financial Results | Market Cap Arena

SYKStryker Corporation

$138B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.5B+11.9% YoY

Gross Profit

$3.4B61.8% margin

Operating Income

$1.2B22.0% margin

Net Income

$834M15.2% margin

EPS (Diluted)

$2.16

QoQ Revenue Growth

+1.3%

Cash Flow

Operating Cash Flow

$1.5B

Free Cash Flow

$1.3B

Stock-Based Comp.

$51M

Balance Sheet

Total Assets

$43.8B

Total Liabilities

$23.7B

Stockholders' Equity

$20.1B

Cash & Equivalents

$3.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.5B	$4.9B	+11.9%
Gross Profit	$3.4B	$3.0B	+12.4%
Operating Income	$1.2B	$991M	+21.9%
Net Income	$834M	$692M	+20.5%

Revenue Segments

MedSurg

$3.2B59%

Orthopaedics and Spine

$2.3B41%

Geographic Segments

United States

$4.1B75%

Non-US

$1.4B25%